Pravin Shende

Employment

• National Institute of Pharmaceutical Education and Research Professor

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (133)

• A highly-sensitive and selective LC–MS/MS platform for quantitative determination of diosgenin in mice plasma with comprehensive bioanalytical validation and pharmacokinetic study
  Annales Pharmaceutiques Françaises 2026 DOI: 10.1016/j.pharma.2026.07.008
  +Save
• Structurally Modified Cyclodextrins in Topical Nanotechnology: Advancing Barrier-Penetrating Drug Delivery Strategies for Psoriasis Management
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-025-03309-y
  +Save
• Advancement in nanotechnology-based formulations for cell repairment in burns
  Journal of Drug Delivery Science and Technology 2025 DOI: 10.1016/j.jddst.2025.107175
  +Save
• Coordination Bond‐Based Nanosystems for Manipulating Niche Framework in Biomedical Applications
  Applied Organometallic Chemistry 2025 DOI: 10.1002/aoc.7978
  +Save
• Strategies for transportation of peptides across the skin for treatment of multiple diseases
  Therapeutic Delivery 2025 DOI: 10.1080/20415990.2024.2411943
  +Save
• Potentiation of Brain Bioavailability Using Thermoreversible Cubosomal Formulation
  Molecular Pharmaceutics 2024 DOI: 10.1021/acs.molpharmaceut.4c00085
  +Save
• Engineering of Layered Nanocarriers of Quercetin for the Treatment of Diabetes Using Box‐Behnken Design
  Particle & Particle Systems Characterization 2024 DOI: 10.1002/ppsc.202300037
  +Save
• Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy
  European Journal of Pharmaceutics and Biopharmaceutics 2024 DOI: 10.1016/j.ejpb.2023.114171
  +Save
• Interdigitation of lipids for vesosomal formulation of ergotamine tartrate with caffeine: a futuristic trend of intranasal route
  Drug Development and Industrial Pharmacy 2024 DOI: 10.1080/03639045.2023.2301018
  +Save
• Anti-CD64 Antibody-Conjugated PLGA Nanoparticles Containing Methotrexate and Gold for Theranostics Application in Rheumatoid Arthritis
  AAPS PharmSciTech 2024 DOI: 10.1208/s12249-024-02733-w
  +Save